In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
GLAXOSMITHKLINE EXERCISES OPTION TO HUMAN GENOME SCIENCES' TRAIL RECEPTOR ANTIBODY
Human Genome Sciences announces license agreement with Amgen
HUMAN GENOME SCIENCES ANNOUNCES DECISION TO SPIN OFF COGENESYS DIVISION AS AN INDEPENDENT COMPANY
Human Genome and Medarex Announce Collaboration
Human Genome Sciences receives AIDS patent
Human Genome Sciences and Praecis form drug discovery partnership
Human Genome Sciences is conducting Repifermin clinicals